Company Overview: Bioline RX Ltd.


Industry News

26 Sep

BioLineRx Announces Initiation of Phase 1b/2 Trial for BL-8040 in AML Under Immunotherapy Collaboration

The BATTLE trial will investigate the combination of BL-8040 and atezolizumab under cancer immunotherapy collaboration TEL AVIV, Israel, September 26, 2017 /PRNewswire/ — BioLineRx Ltd. (BLRX) (BLRX.TA), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today the initiation of a Phase 1b/2 trial for BL-8040 in combination with atezolizumab...

Read more

7 Sep

BioLineRx to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York

TEL AVIV, Israel, September 7, 2017 /PRNewswire/ — BioLineRx Ltd. (BLRX)(BLRX.TA), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that its Chief Executive Officer, Philip Serlin, and its Chief Business Officer, David Malek, will present a company update at the 19th Annual Rodman & Renshaw Global Investment Conference at the...

Read more

8 Aug

Investor Network: Bioline RX Ltd Sponsored ADR to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Bioline RX Ltd Sponsored ADR (NASDAQ: BLRX) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, 2017 at 10:00 AM Eastern Time. To listen to the event live – visit https://www.investornetwork.com/company/23623. Replay Information The replay...

Read more

8 Aug

BioLineRx Reports Second Quarter 2017 Financial Results

TEL AVIV, Israel, Aug. 8, 2017 /PRNewswire/ — BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today reports its financial results for the second quarter ended June 30, 2017. Highlights and achievements during the second quarter 2017 and to date: Continued execution on multiple clinical development programs for the...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address